ViGenCell Inc. Logo

ViGenCell Inc.

Develops immune cell therapies to treat cancer and other incurable diseases.

308080 | KO

Overview

Corporate Details

ISIN(s):
KR7308080001
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산로9길 66 더리즌밸리 지식산업센터(가산동), 서울특별시

Description

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean 40.7 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.1 MB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.2 MB
2025-04-30 00:00
기타경영사항(자율공시) (iPSC(유도만능줄기세포) 유래 NK세포치료제 공동개발계약 체결)
Korean 6.8 KB
2025-04-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.6 KB
2025-03-27 00:00
정기주주총회결과
Korean 33.6 KB
2025-03-27 00:00
대표이사변경
Korean 10.6 KB
2025-03-19 00:00
감사보고서제출
Korean 25.3 KB
2025-03-19 00:00
사업보고서 (2024.12)
Korean 395.3 KB
2025-03-13 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-03-13 00:00
주식등의대량보유상황보고서(일반)
Korean 90.2 KB
2025-03-12 00:00
주주총회소집공고
Korean 818.4 KB
2025-03-11 00:00
주식매수선택권행사
Korean 17.9 KB

Automate Your Workflow. Get a real-time feed of all ViGenCell Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ViGenCell Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ViGenCell Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.